The entire world has been severely affected by the ongoing Covid-19 pandemic. The severity of symptoms that occur during the Covid-19 infection can range from undetectable to life-threatening. The quick testing procedure involves antigen testing which provides the result for hundreds of samples within a short span of time.
Several innovators and entrepreneurs have been working tirelessly for developing accurate, affordable and accessible testing kits for not only providing aid to the healthcare workers in such tough times for easy detection but also for boosting the biotechnology ecosystem in India.
Under the aegis of Covid-19 Research Consortium, DBT-BIRAC supported product Sensit Rapid Covid-19 Ag kit has been developed by Ubio Biotechnology Systems Pvt Ltd for the qualitative detection of SARS CoV-2 Nucleocapsid Protein with an assay time of 15 minutes.
The samples are collected using nasopharyngeal swabs from the suspected individual. This ICMR approved kit is a chromatographic immunoassay, which allows the healthcare personnel to visually read the test result, Ministry of Science & Technology has said.
The test works on the principle of sandwich immunoassay and utilises a pair of monoclonal antibodies which when bound to the Covid-19 specific antigen, resulting in the appearance of a coloured line. The kit exhibits sensitivity and specificity of 86% and 100%, respectively and has a shelf life of 24 months. The Sensit Rapid Covid-19 Ag Kit has been successfully commercialized, it added.
Such quick tests allow healthcare professionals to detect infected individuals quickly, saving their time and allowing them to provide better advice and treatment to the infected individual.